N-Acylated Sulfonamide Sodium Salt: A Prodrug of Choice for the Bifunctional...

1
2006 Antiinflammatory activity X 0130 N-Acylated Sulfonamide Sodium Salt: A Prodrug of Choice for the Bifunctional 2-Hydroxymethyl-4-(5-phenyl-3-trifluoromethyl-pyrazol-1-yl) Benzenesulfon- amide Class of COX-2 Inhibitors. — The conversion of potent COX-2 inhibitors, inactive in vivo, to potent antiinflammatory drug candidates is demonstrated by means of a prodrug approach. Prodrugs (I) are identified as potential agents for oral as well as parenteral administration. — (SINGH*, S. K.; VOBBALAREDDY, S.; KALLEDA, S. R.; CASTURI, S. R.; MULLANGI, R.; RAMANUJAM, R.; YELESWARAPU, K. R.; IQBAL, J.; Bioorg. Med. Chem. Lett. 16 (2006) 15, 3921-3926; Chem.-Discovery Res., Dr. Reddy's Lab. Ltd., Hyderabad 500 049, India; Eng.) — H. Hoennerscheid 45- 219

Transcript of N-Acylated Sulfonamide Sodium Salt: A Prodrug of Choice for the Bifunctional...

Page 1: N-Acylated Sulfonamide Sodium Salt: A Prodrug of Choice for the Bifunctional 2-Hydroxymethyl-4-(5-phenyl-3-trifluoromethyl-pyrazol-1-yl) Benzenesulfonamide Class of COX-2 Inhibitors.

2006

Antiinflammatory activityX 0130 N-Acylated Sulfonamide Sodium Salt: A Prodrug of Choice for the Bifunctional

2-Hydroxymethyl-4-(5-phenyl-3-trifluoromethyl-pyrazol-1-yl) Benzenesulfon-amide Class of COX-2 Inhibitors. — The conversion of potent COX-2 inhibitors, inactive in vivo, to potent antiinflammatory drug candidates is demonstrated by means of a prodrug approach. Prodrugs (I) are identified as potential agents for oral as well as parenteral administration. — (SINGH*, S. K.; VOBBALAREDDY, S.; KALLEDA, S. R.; CASTURI, S. R.; MULLANGI, R.; RAMANUJAM, R.; YELESWARAPU, K. R.; IQBAL, J.; Bioorg. Med. Chem. Lett. 16 (2006) 15, 3921-3926; Chem.-Discovery Res., Dr. Reddy's Lab. Ltd., Hyderabad 500 049, India; Eng.) — H. Hoennerscheid

45- 219